Skip to Main Content
Georgetown University’s Newspaper of Record since 1920

The Hoya

Georgetown University’s Newspaper of Record since 1920

The Hoya

Georgetown University’s Newspaper of Record since 1920

The Hoya

MedStar Georgetown University Hospital is one of the first in the country to begin implementing tumor-infiltrating lymphocyte (TIL) therapy, a new treatment for metastatic melanoma that trains a patient’s own immune system and tumor to fight the cancer, the hospital announced Jan. 8.

GU Hospital Rolls Out Breakthrough Melanoma Treatment

By Ajani Stella, Academics Desk Editor January 15, 2025

The MedStar Georgetown University Hospital began implementing a new treatment for metastatic melanoma that fights a patient’s cancer using their own immune system and cancerous cells, the hospital announced...

Down with Pharmaceutical Costs

By Nikita Deshpande September 7, 2015

Hepatitis C officially has a cure: Sovaldi. It is a powerful drug capable of healing the 150-200 million hepatitis C sufferers around the world. This pharmaceutical discovery entered the market in 2014...

Load More Stories
Donate to The Hoya